Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Illinois at Chicago
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Previously diagnosed with T1DM and currently using insulin
HbA1c: 6.5-9.5% (regardless of medication use)
Age between 18 to 75 years old
BMI between 25 and 50 kg/m2
Independently living (i.e., subjects who do not live in a nursing home or institution)
On either multiple daily doses of insulin injections (MDII) or using an insulin pump (with or without closed loop feature)
Active prescription for daily use of a continous glucose monitor (CGM) or willing to be provided with a CGM during the study (at no cost)
Active prescription for glucagon
You may not be if
History of severe hypoglycemia defined as requiring help from others, needed to use emergency glucagon administration in the past 6 months.
Medical history of heart failure, unstable coronary artery disease, chronic obstructive pulmonary disease, requiring oxygen, cirrhosis, active cancer, history of stroke, cognitive impairment, end stage renal disease (eGFR ≤30 ml/min/m2)
Previously diagnosed with T2DM
Have a history of eating disorders (anorexia, bulimia, or binge eating disorder)
Are not weight stable for 3 months prior to the beginning of study (weight gain or loss \> 4%)
Are not able to keep a food diary for 7 consecutive days during screening
Are taking certain drugs that have significant weight loss outcomes (weight loss medications, specifically GLP1 agonist, GLP-1/GIP agonists)
Are eating less than a 10-hour window at baseline
Are perimenopausal (menses does not appear every 27-32d)
Are pregnant, or trying to become pregnant
Are night shift workers
Clareo Health | Intermittent Fasting in Adults With Type 1 Diabetes
